DPP4 deficiency preserved cardiac function in abdominal aortic banding rats

Area of Science:

• Cardiovascular Biology
• Metabolic Disease Research
• Enzyme Function Studies

Background:

• Dipeptidyl peptidase-4 (DPP4) enzyme inhibition increases glucagon-like peptide-1 (GLP-1) levels, aiding glucose control.
• DPP4 deficiency confers resistance to endotoxemia, myocardial infarction, and oxidative stress.
• The long-term impact of DPP4 deficiency on cardiac function under chronic stress is not well understood.

Purpose of the Study:

• To investigate the long-term effects of DPP4 deficiency on cardiac performance during pressure overload.
• To determine if DPP4 deficiency mitigates the progression of heart failure induced by abdominal aortic banding (AAB).

Main Methods:

• Induced pressure overload in wild-type and DPP4-deficient rats using abdominal aortic banding (AAB).
• Assessed cardiac histology, cardiac function, and plasma biochemical markers over 10 weeks.
• Measured DPP4 activity, GLP-1, and Angiotensin II (Ang II) levels, and quantified cardiac collagen deposition.

Main Results:

• AAB surgery led to cardiac dysfunction and increased heart weight to body weight ratio in wild-type rats after 10 weeks.
• DPP4-deficient rats exhibited alleviated cardiac dysfunction and reduced collagen deposits compared to wild-type rats post-AAB.
• GLP-1 levels remained elevated in DPP4-deficient rats throughout the study, while Ang II levels were lower compared to wild-type rats.

Conclusions:

• Long-term deficiency of DPP4 activity improves cardiac performance and reduces cardiac fibrosis in response to pressure overload.
• Elevated GLP-1 levels due to DPP4 deficiency likely contribute to the cardioprotective effects observed during pressure overload.
• DPP4 deficiency represents a potential therapeutic target for managing heart failure under chronic stress conditions.